Your shopping cart is currently empty

MDM2/XIAP-IN-1 (compound 14) is an orally active dual inhibitor of MDM2 and XIAP, displaying anti-cancer activity with an IC50 of 0.3 μM and potential applications in cancer research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MDM2/XIAP-IN-1 (compound 14) is an orally active dual inhibitor of MDM2 and XIAP, displaying anti-cancer activity with an IC50 of 0.3 μM and potential applications in cancer research [1]. |
| In vitro | The chemical compound MDM2/XIAP-IN-1, at a concentration of 0-4 μM administered over a period of 2 weeks, inhibits the cellular activity of EU-1, EU-3, NB-1643, SHEP, and LA1-55n cell lines [1]. |
| In vivo | MDM2/XIAP-IN-1 Pharmacokinetic Profile in Male SD Rats [1] Pharmacokinetic Analysis [1]: Intravenous administration at a dose of 10 mg/kg resulted in an AUC_last of 4750 ng·h/mL, a half-life (t_1/2) of 0.94 hours, and an observed clearance (Cl_obs) of 2.12 L·h/kg. Oral dosing at 25 mg/kg exhibited an AUC_last of 0.71 ng·h/mL and a bioavailability (F) of 5.9%. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.